this review summarises the electrophysiological , haemodynamic , pharmacokinetic , and efficacy and safety data of mexiletine , tocainide , flecainide , encainide , propafenone , amiodarone , sotalol , pirmenol , cibenzoline ( cifenline ) and ethmozine ( moracizine , moricizine ) , and aims to provide a basis on which clinicians can compare and contrast these agents and form an algorithm for selection of antiarrhythmic drug therapy in the treatment of patients with ventricular arrhythmias .
C0033429
propafenone
C0003195
antiarrhythmic